Phospholamban overexpression in transgenic rabbits

James Scott Pattison, Jason R. Waggoner, Jeanne James, Lisa Martin, James Gulick, Hanna Osinska, Raisa Klevitsky, Evangelia G. Kranias, Jeffrey Robbins

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

There has been considerable interest in pursuing phospholamban as a putative therapeutic target for overcoming depressed calcium handling in human heart failure. Studies predominantly done in mice have shown that phospholamban is a key regulator of sarcoplasmic reticulum calcium cycling and cardiac function. However, mice differ significantly from humans in how they regulate calcium, whereas rabbits better recapitulate human cardiac function and calcium handling. To investigate phospholamban's role in the rabbit heart, transgenic rabbits that overexpressed wild-type phospholamban in the ventricular cardiomyocytes and slow-twitch skeletal muscles were generated. Rabbits expressing high levels of phospholamban were not viable due to severe skeletal muscle wasting, the onset of cardiac pathology and early death. A viable transgenic line exhibited a 30% increase in PLN protein levels in the heart. These animals showed isolated foci of cardiac pathology, but cardiac function as well as the response to β-adrenergic stimulation were normal. SR-calcium uptake measurements showed that the transgenic hearts had the expected reduced affinity for calcium. The data show that phospholamban-overexpressing transgenic rabbits differ markedly in phenotype from analogous transgenic mice in that rabbits are quite sensitive to alterations in phospholamban levels. Exceeding a relatively narrow window of phospholamban expression results in significant morbidity and early death.

Original languageEnglish (US)
Pages (from-to)157-170
Number of pages14
JournalTransgenic Research
Volume17
Issue number2
DOIs
StatePublished - Apr 1 2008

Fingerprint

rabbits
genetically modified organisms
Rabbits
calcium
cardiac output
Calcium
heart
skeletal muscle
mice
death
Skeletal Muscle
sarcoplasmic reticulum
heart failure
Pathology
morbidity
phospholamban
Sarcoplasmic Reticulum
Cardiac Myocytes
Adrenergic Agents
Transgenic Mice

Keywords

  • Calcium
  • Heart failure
  • Phospholamban
  • Transgenic rabbits

ASJC Scopus subject areas

  • Biotechnology
  • Animal Science and Zoology
  • Genetics
  • Agronomy and Crop Science

Cite this

Pattison, J. S., Waggoner, J. R., James, J., Martin, L., Gulick, J., Osinska, H., ... Robbins, J. (2008). Phospholamban overexpression in transgenic rabbits. Transgenic Research, 17(2), 157-170. https://doi.org/10.1007/s11248-007-9139-2

Phospholamban overexpression in transgenic rabbits. / Pattison, James Scott; Waggoner, Jason R.; James, Jeanne; Martin, Lisa; Gulick, James; Osinska, Hanna; Klevitsky, Raisa; Kranias, Evangelia G.; Robbins, Jeffrey.

In: Transgenic Research, Vol. 17, No. 2, 01.04.2008, p. 157-170.

Research output: Contribution to journalArticle

Pattison, JS, Waggoner, JR, James, J, Martin, L, Gulick, J, Osinska, H, Klevitsky, R, Kranias, EG & Robbins, J 2008, 'Phospholamban overexpression in transgenic rabbits', Transgenic Research, vol. 17, no. 2, pp. 157-170. https://doi.org/10.1007/s11248-007-9139-2
Pattison JS, Waggoner JR, James J, Martin L, Gulick J, Osinska H et al. Phospholamban overexpression in transgenic rabbits. Transgenic Research. 2008 Apr 1;17(2):157-170. https://doi.org/10.1007/s11248-007-9139-2
Pattison, James Scott ; Waggoner, Jason R. ; James, Jeanne ; Martin, Lisa ; Gulick, James ; Osinska, Hanna ; Klevitsky, Raisa ; Kranias, Evangelia G. ; Robbins, Jeffrey. / Phospholamban overexpression in transgenic rabbits. In: Transgenic Research. 2008 ; Vol. 17, No. 2. pp. 157-170.
@article{03bcc88d1a9e48daaafa45ac42a5377c,
title = "Phospholamban overexpression in transgenic rabbits",
abstract = "There has been considerable interest in pursuing phospholamban as a putative therapeutic target for overcoming depressed calcium handling in human heart failure. Studies predominantly done in mice have shown that phospholamban is a key regulator of sarcoplasmic reticulum calcium cycling and cardiac function. However, mice differ significantly from humans in how they regulate calcium, whereas rabbits better recapitulate human cardiac function and calcium handling. To investigate phospholamban's role in the rabbit heart, transgenic rabbits that overexpressed wild-type phospholamban in the ventricular cardiomyocytes and slow-twitch skeletal muscles were generated. Rabbits expressing high levels of phospholamban were not viable due to severe skeletal muscle wasting, the onset of cardiac pathology and early death. A viable transgenic line exhibited a 30{\%} increase in PLN protein levels in the heart. These animals showed isolated foci of cardiac pathology, but cardiac function as well as the response to β-adrenergic stimulation were normal. SR-calcium uptake measurements showed that the transgenic hearts had the expected reduced affinity for calcium. The data show that phospholamban-overexpressing transgenic rabbits differ markedly in phenotype from analogous transgenic mice in that rabbits are quite sensitive to alterations in phospholamban levels. Exceeding a relatively narrow window of phospholamban expression results in significant morbidity and early death.",
keywords = "Calcium, Heart failure, Phospholamban, Transgenic rabbits",
author = "Pattison, {James Scott} and Waggoner, {Jason R.} and Jeanne James and Lisa Martin and James Gulick and Hanna Osinska and Raisa Klevitsky and Kranias, {Evangelia G.} and Jeffrey Robbins",
year = "2008",
month = "4",
day = "1",
doi = "10.1007/s11248-007-9139-2",
language = "English (US)",
volume = "17",
pages = "157--170",
journal = "Transgenic Research",
issn = "0962-8819",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Phospholamban overexpression in transgenic rabbits

AU - Pattison, James Scott

AU - Waggoner, Jason R.

AU - James, Jeanne

AU - Martin, Lisa

AU - Gulick, James

AU - Osinska, Hanna

AU - Klevitsky, Raisa

AU - Kranias, Evangelia G.

AU - Robbins, Jeffrey

PY - 2008/4/1

Y1 - 2008/4/1

N2 - There has been considerable interest in pursuing phospholamban as a putative therapeutic target for overcoming depressed calcium handling in human heart failure. Studies predominantly done in mice have shown that phospholamban is a key regulator of sarcoplasmic reticulum calcium cycling and cardiac function. However, mice differ significantly from humans in how they regulate calcium, whereas rabbits better recapitulate human cardiac function and calcium handling. To investigate phospholamban's role in the rabbit heart, transgenic rabbits that overexpressed wild-type phospholamban in the ventricular cardiomyocytes and slow-twitch skeletal muscles were generated. Rabbits expressing high levels of phospholamban were not viable due to severe skeletal muscle wasting, the onset of cardiac pathology and early death. A viable transgenic line exhibited a 30% increase in PLN protein levels in the heart. These animals showed isolated foci of cardiac pathology, but cardiac function as well as the response to β-adrenergic stimulation were normal. SR-calcium uptake measurements showed that the transgenic hearts had the expected reduced affinity for calcium. The data show that phospholamban-overexpressing transgenic rabbits differ markedly in phenotype from analogous transgenic mice in that rabbits are quite sensitive to alterations in phospholamban levels. Exceeding a relatively narrow window of phospholamban expression results in significant morbidity and early death.

AB - There has been considerable interest in pursuing phospholamban as a putative therapeutic target for overcoming depressed calcium handling in human heart failure. Studies predominantly done in mice have shown that phospholamban is a key regulator of sarcoplasmic reticulum calcium cycling and cardiac function. However, mice differ significantly from humans in how they regulate calcium, whereas rabbits better recapitulate human cardiac function and calcium handling. To investigate phospholamban's role in the rabbit heart, transgenic rabbits that overexpressed wild-type phospholamban in the ventricular cardiomyocytes and slow-twitch skeletal muscles were generated. Rabbits expressing high levels of phospholamban were not viable due to severe skeletal muscle wasting, the onset of cardiac pathology and early death. A viable transgenic line exhibited a 30% increase in PLN protein levels in the heart. These animals showed isolated foci of cardiac pathology, but cardiac function as well as the response to β-adrenergic stimulation were normal. SR-calcium uptake measurements showed that the transgenic hearts had the expected reduced affinity for calcium. The data show that phospholamban-overexpressing transgenic rabbits differ markedly in phenotype from analogous transgenic mice in that rabbits are quite sensitive to alterations in phospholamban levels. Exceeding a relatively narrow window of phospholamban expression results in significant morbidity and early death.

KW - Calcium

KW - Heart failure

KW - Phospholamban

KW - Transgenic rabbits

UR - http://www.scopus.com/inward/record.url?scp=41049089262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41049089262&partnerID=8YFLogxK

U2 - 10.1007/s11248-007-9139-2

DO - 10.1007/s11248-007-9139-2

M3 - Article

C2 - 17882530

AN - SCOPUS:41049089262

VL - 17

SP - 157

EP - 170

JO - Transgenic Research

JF - Transgenic Research

SN - 0962-8819

IS - 2

ER -